Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management
- DOI
- 10.1002/hem3.70404
- Published
- 2026-06
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70404,
title = {Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management},
author = {Jan‐Michael Werner and Philipp Gödel and Norbert Galldiks and Christopher Krone and Michael Schroeter and Udo Holtick and Ruth Flümann and Gilbert Wunderlich and Michael Hallek and Gereon R. Fink and Christoph Scheid and Oezguer A. Onur and Tim Richardson},
year = {2026},
journal = {HemaSphere},
doi = {10.1002/hem3.70404},
url = {https://doi.org/10.1002/hem3.70404}
}RIS
TY - JOUR TI - Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management AU - Jan‐Michael Werner AU - Philipp Gödel AU - Norbert Galldiks AU - Christopher Krone AU - Michael Schroeter AU - Udo Holtick AU - Ruth Flümann AU - Gilbert Wunderlich AU - Michael Hallek AU - Gereon R. Fink AU - Christoph Scheid AU - Oezguer A. Onur AU - Tim Richardson PY - 2026 JO - HemaSphere DO - 10.1002/hem3.70404 UR - https://doi.org/10.1002/hem3.70404 ER -
APA
Werner, J., Gödel, P., Galldiks, N., Krone, C., Schroeter, M., Holtick, U., Flümann, R., Wunderlich, G., Hallek, M., Fink, G. R., Scheid, C., Onur, O. A., & Richardson, T. (2026). Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management. HemaSphere. https://doi.org/10.1002/hem3.70404
Source records
- crossref · retrieved 2026-09-25T02:29:09.076Z